Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Une étude du mezagitamab chez les adultes atteints de la néphropathie IGA primaire condition rénale

3 novembre 2026 mis à jour par: Takeda

Un essai multicentrique de phase 3, randomisé, en double aveugle et contrôlé par placebo pour évaluer l'efficacité et la sécurité du mezagitamab (TAK-079) dans les participants à l'étude atteints de néphropathie IgA primaire en combinaison avec une thérapie de fond stable

Immunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when the body's immune system creates groups of proteins (called immune complexes) that build-up in the kidneys causing swelling (inflammation). Over time, this inflammation may lead to kidney damage and cause the kidneys to no longer work properly. The main aim of this study is to check how well mezagitamab changes protein levels in the urine (proteinuria) compared to placebo in adults with primary IgAN. A placebo looks like medicine but doesn't have any active ingredients in it. Other aims are to check how safe mezagitamab is and how well participants with primary IgAN can tolerate it compared to placebo, and to find out if and how well mezagitamab continues to maintain kidney function over the long term compared to placebo.

Participants will be placed in 1 of the 2 treatment groups; the main group and the open-label group. In the main group, participants will be placed by chance in either the mezagitamab or placebo treatment group at a 2:1 ratio. This means that out of 3 participants, 2 will receive mezagitamab and 1 will receive placebo. Participants can be in the study for 2 years (104 weeks). Participants will receive study treatment for about half a year (22 weeks) and then be observed for the remainder of the study (about 1.5 years). During observation, participants will continue to have check-ups about every month.

In the open-label group, a small number of participants who either have lower levels of protein in their urine or have kidneys that do not filter the blood well, will receive mezagitamab treatment. This will include participants who have previously received mezagitamab in another study, TAK-079-1006. Every participant will receive mezagitamab in the same way as those in the main group receiving mezagitamab.

During the study, participants will visit their study clinic several times.

Aperçu de l'étude

Statut

Recrutement

Les conditions

Type d'étude

Interventionnel

Inscription (Estimé)

347

Phase

  • Phase 3

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

      • Mainz, Allemagne, 55131
        • Recrutement
        • Universitaetsmedizin der Johannes - Gutenberg Universitaet Mainz
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Julia Weinmann-Manke
    • North Rhine-Westphalia
      • Aachen, North Rhine-Westphalia, Allemagne, 52074
        • Recrutement
        • Uniklinik RWTH Aachen
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Claudia Seikrit
    • Thuringia
      • Jena, Thuringia, Allemagne, 7747
        • Recrutement
        • Universitaetsklinikum Jena
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Martin Busch
      • Ciudad Autonoma Buenos Aires, Argentine, 1280
        • Recrutement
        • Hospital Britanico de Buenos Aires
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Hernan Trimarchi Jurado
      • Córdoba, Argentine, X5016
        • Recrutement
        • Clinica Privada Velez Sarsfield
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Rafael Alberto Maldonado
    • Buenos Aires
      • Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentine, C1425AGC
        • Recrutement
        • Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Alejandra Smuclir Quevedo
    • La Plata
      • Buenos Aires, La Plata, Argentine, 1902
        • Recrutement
        • Framingham Centro Medico
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Martin Mamberti
    • New South Wales
      • Liverpool, New South Wales, Australie
        • Recrutement
        • South Western Sydney Local Health District - University of New South Wales - Liverpool Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Beata Zahorowska
    • Queensland
      • Milton, Queensland, Australie
        • Recrutement
        • Core Research Group
        • Contact:
          • Site Contact
        • Chercheur principal:
          • David Colquhoun
    • Victoria
      • Box Hill, Victoria, Australie, 3128
        • Recrutement
        • Eastern Health
        • Chercheur principal:
          • Darren Lee
        • Contact:
          • Site Contact
      • Clayton, Victoria, Australie
        • Recrutement
        • Monash Heath - Monash University - Monash Medical Centre
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Jessica Ryan
      • St Albans, Victoria, Australie, 3021
        • Recrutement
        • Western Health Sunshine Hospital
        • Chercheur principal:
          • Eugenia Pedagogos
        • Contact:
          • Site Contact
    • Alberta
      • Calgary, Alberta, Canada, T2R 0X7
        • Recrutement
        • Sheldon M. Chumir Health Centre
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Louis Girard
    • Ontario
      • London, Ontario, Canada, N6A5A5
        • Recrutement
        • London Health Sciences Centre
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Matthew Weir
      • Toronto, Ontario, Canada, M4G 3E8
        • Recrutement
        • Sunnybrook Health Sciences Centre
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Michelle Hladunewich
    • Beijing Municipality
      • Beijing, Beijing Municipality, Chine, 100034
        • Recrutement
        • Peking University First Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Jicheng Lv
      • Changping, Beijing Municipality, Chine, 102218
        • Recrutement
        • Beijing Tsinghua Changgung Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Yuehong Li
    • Fujian
      • Xiamen, Fujian, Chine, 361004
        • Recrutement
        • Zhongshan Hospital Xiamen University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Bo Xu
    • Guangdong
      • Guangdong, Guangdong, Chine, Guangdong
        • Recrutement
        • The First Affiliated Hospital of Sun Yat-sen University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Wei Chen
      • Guangzhou, Guangdong, Chine, 510080
        • Recrutement
        • Guangdong General Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Zhiming Ye
      • Shenzhen, Guangdong, Chine, 518000
        • Recrutement
        • Peking University Shenzhen Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Zu-Ying Xiong
    • Hunan
      • Changsha, Hunan, Chine, 410013
        • Recrutement
        • The Third Xiangya Hospital of Central South University Yuelu District
        • Chercheur principal:
          • Hao Zhang
        • Contact:
          • Site Contact
    • Inner Mongolia
      • Baotou, Inner Mongolia, Chine, 14010
        • Recrutement
        • The First Affiliated Hospital of Baotou Medical College
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Zengyan Li
    • Jiangsu
      • Nanjing, Jiangsu, Chine, 210009
        • Recrutement
        • Zhongda Hospital Southeast University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Liu Bicheng
      • Nantong, Jiangsu, Chine, 226001
        • Recrutement
        • Affiliated Hospital of Nantong University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Xinzhong Huang
      • Wuxi, Jiangsu, Chine, 214023
        • Recrutement
        • Wuxi People's Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Liang Wang
    • Jiangxi
      • Nanchang, Jiangxi, Chine, 330006
        • Recrutement
        • The First Affiliated Hospital of Nanchang University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Yan Yan
    • Shandong
      • Jinan, Shandong, Chine, 250012
        • Recrutement
        • Shandong University - Qilu Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Xiang-Dong Yang
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Chine, 200000
        • Recrutement
        • Shanghai Jiao Tong University School of Medicine (SJTUSM) - Renji Hospital - Eastern Branch
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Leyi Gu
      • Shanghai, Shanghai Municipality, Chine, 200025
        • Recrutement
        • Ruijin Hospital of Shanghai Jiaotong University School of Medicine
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Jingyuan Xie
    • Sichuan
      • Chengdu, Sichuan, Chine, 610000
        • Recrutement
        • West China Hospital Sichuan University
        • Chercheur principal:
          • Ping Fu
        • Contact:
          • Site Contact
      • Chengdu, Sichuan, Chine, 610072
        • Recrutement
        • Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Guisen Li
      • Yibin, Sichuan, Chine, 644099
        • Recrutement
        • The Second People's Hospital of Yibin
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Deqiong Xie
    • Xiangzhou District, Guangdong Province
      • Zhuhai, Xiangzhou District, Guangdong Province, Chine, 519000
        • Recrutement
        • Fifth Affiliated Hospital Sun Yat-Sen University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Cheng Wang
    • Zhejiang
      • Hangzhou, Zhejiang, Chine
        • Recrutement
        • The Second Affiliated Hospital, Zhejiang University, School of Medicine
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Kunling Ma
      • Ningbo, Zhejiang, Chine, 315010
        • Recrutement
        • The First Affiliated Hospital of Ningbo University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Xueyan Bian
      • Seoul, Corée du Sud, 3722
        • Recrutement
        • Severance Hospital, Yonsei University Health System
        • Chercheur principal:
          • Seung Hyeok Han
        • Contact:
          • Site Contact
      • Seoul, Corée du Sud, 3080
        • Recrutement
        • Seoul National University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Dong Ki Kim
      • Seoul, Corée du Sud, 7061
        • Recrutement
        • Seoul National University Boramae Medical Center
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Jung Pyo Lee
    • Gyeonggi-do
      • Yongin-si, Gyeonggi-do, Corée du Sud, 16995
        • Recrutement
        • Yongin Severance Hospital, Yonsei University Health System
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Young Su Joo
    • Gyeonggido
      • Suwon, Gyeonggido, Corée du Sud, 16499
        • Recrutement
        • Ajou University Hospital-Primary Research Location
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Inwhee Park
    • Seongnam
      • Seongnam-si, Seongnam, Corée du Sud, 13620
        • Recrutement
        • Seoul National University Bundang Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Ho-Jun Chin
      • Barcelona, Espagne, 8035
        • Recrutement
        • Hospital Universitari Vall d'Hebron
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Irene Agraz Pamplona
      • Barcelona, Espagne, 8003
        • Recrutement
        • Hospital del Mar
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Eva Rodriguez Garcia
      • Madrid, Espagne, 28027
        • Recrutement
        • Universidad de Navarra - Clinica Universidad de Navarra
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Jose Maria Mora Gutierrez
      • Madrid, Espagne, 28040
        • Recrutement
        • Fundacion Jimenez Diaz
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Roberto Scarpioni
      • Seville, Espagne, 41013
        • Recrutement
        • Hospital Universitario Virgen del Rocio - PPDS
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Manuel Lopez Mendoza
    • Barcelona
      • Badalona, Barcelona, Espagne, 8915
        • Recrutement
        • Hospital Universitari Germans Trias i Pujol
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Iara Karlla Da Silva Santos
    • Bizkaia
      • Barakaldo, Bizkaia, Espagne, 48903
        • Recrutement
        • Hospital Universitario de Cruces
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Laura Bueno Lopez
    • Navarre
      • Pamplona, Navarre, Espagne, 31008
        • Recrutement
        • Universidad de Navarra - Clinica Universidad de Navarra
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Jose Maria Mora Gutierrez
      • Bordeaux, France, 33076
        • Recrutement
        • CHU Bordeaux, CHU Pellegrin
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Claire Rigothier
      • Limoges, France, 87042
        • Recrutement
        • CHU Limoges Service de Nephrology
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Fatouma Toure
      • Montpellier, France, 34090
        • Recrutement
        • Centre Hospitalier Universitaire de Montpellier (CHU Montpellier) - Hopital Lapeyronie
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Moglie Le Quintrec
      • Nantes, France, 44093
        • Recrutement
        • CHU de Nantes
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Simon Ville
      • Paris, France, 75020
        • Recrutement
        • Hospital Tenon
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Khalil Karoui
    • Paris
      • Créteil, Paris, France, 94000
        • Recrutement
        • Hospital Henri Mondor
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Vincent Audard
    • Hong Kong Island
      • Hong Kong, Hong Kong Island, Hong Kong
        • Recrutement
        • The University of Hong Kong - Department of Medicine
        • Chercheur principal:
          • Sydney Chi Wai Tang
        • Contact:
          • Site Contact
      • Budapest, Hongrie, 1083
        • Recrutement
        • Semmelweis Egyetem - Belgyogyaszati es Onkologiai Klinika (I.sz. Belgyogyaszati Klinika)
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Akos Petho
      • Bologna, Italie, 40138
        • Recrutement
        • IRCCS Azienda Ospedaliero-Universitaria di Bologna
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Gaetano La Manna
      • Brescia, Italie, 25124
        • Recrutement
        • ASST degli Spedali Civili di Brescia - Spedali Civili di Brescia
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Federica Mescia
      • Genoa, Italie, 16132
        • Recrutement
        • IRCCS Ospedale Policlinico San Martino
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Francesca Viazzi
      • Messina, Italie, 98122
        • Recrutement
        • Az Ospedaliera Universitaria Policlinico G Martino
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Domenico Santoro
      • Milan, Italie, 20100
        • Recrutement
        • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Giuseppe Castellano
      • Pavia, Italie, 27100
        • Recrutement
        • Istituto Maugeri IRCCS Pavia
        • Chercheur principal:
          • Ciro Esposito
        • Contact:
          • Site Contact
      • Piacenza, Italie, 29121
        • Recrutement
        • Azienda Unita Sanitaria Locale Piacenza (AUSL) Ospedale "Guglielmo da Saliceto
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Roberto Scarpioni
      • Torino, Italie, 10126
        • Recrutement
        • AOU Citta della Salute e della Scienza di Torino
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Luigi Biancone
    • Aichi-ken
      • Kasugai-Shi, Aichi-ken, Japon, 486-8510
        • Recrutement
        • Kasugai Municipal Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Yosuke Saka
      • Nagoya, Aichi-ken, Japon, 466-8650
        • Recrutement
        • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Shoji Saito
      • Toyoake-shi, Aichi-ken, Japon, 470-1192
        • Recrutement
        • Fujita Health University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Naotake Tsuboi
    • Chiba
      • Chiba, Chiba, Japon, 260-8712
        • Recrutement
        • National Hospital Organization Chiba Medical Center Chibahigashi National Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Takehiko Kawaguchi
    • Fukuoka
      • Fukuoka, Fukuoka, Japon, 812-8582
        • Recrutement
        • Kyushu University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Toshiaki Nakano
    • Fukushima
      • Fukushima, Fukushima, Japon, 960-1295
        • Recrutement
        • Fukushima Medical University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Kazama Junichiro
    • Hiroshima
      • Hiroshima, Hiroshima, Japon, 734-8551
        • Recrutement
        • Hiroshima University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Takao Masaki
    • Hokkaido
      • Sapporo, Hokkaido, Japon, 060-8648
        • Recrutement
        • Hokkaido University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Daigo Nakazawa
    • Kanagawa
      • Kamakura-shi, Kanagawa, Japon, 247-8533
        • Recrutement
        • Shonan Kamakura General Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Hidaka Sumi
      • Kawasaki-shi, Kanagawa, Japon, 213-8587
        • Recrutement
        • Toranomon Hospital Kajigaya
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Naoki Sawa
      • Yokohama, Kanagawa, Japon, 236-0004
        • Recrutement
        • Yokohama City University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Kouichi Tamura
    • Miyagi
      • Sendai, Miyagi, Japon, 981-3281
        • Recrutement
        • Japan Community Health care Organization Sendai Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Santoru Sanada
    • Nara
      • Kashihara-shi, Nara, Japon, 634-8522
        • Recrutement
        • Nara Medical University Hospital
        • Chercheur principal:
          • Kazuhiko Tsuruya
        • Contact:
          • Site Contact
      • Nara, Nara, Japon, 630-8581
        • Recrutement
        • Nara Prefecture General Medical Center
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Hideo Tsushima
    • Oita Prefecture
      • Yufu-shi, Oita Prefecture, Japon, 879-5593
        • Recrutement
        • Oita University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Fukuda Akihiro
    • Osaka
      • Osaka, Osaka, Japon, 530-8480
        • Recrutement
        • Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofuka
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Takeshi Matsubara
    • Saitama
      • Koshigaya-shi, Saitama, Japon, 343-8555
        • Recrutement
        • Dokkyo Medical University Saitama Medical Center
        • Chercheur principal:
          • Tetsuro Takeda
        • Contact:
          • Site Contact
    • Tokyo
      • Bunkyo-ku, Tokyo, Japon, 113-8431
        • Recrutement
        • Juntendo University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Yusuke Suzuki
      • Shinjuku-Ku, Tokyo, Japon, 160-0023
        • Recrutement
        • Tokyo Medical University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Takahito Moriyama
    • Yamanashi
      • Chuo-shi, Yamanashi, Japon, 409-3898
        • Recrutement
        • University of Yamanashi Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Ayumu Nakashima
      • Linz, L'Autriche, 4040
        • Recrutement
        • Johannes Kepler Universitat Linz, Universitatsklinik fur Innere 2
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Alexander Moschen
      • Vienna, L'Autriche, 1090
        • Recrutement
        • Medizinische Universitat Wien (Medical University of Vienna - Austria)
        • Chercheur principal:
          • Rainer Oberbauer
        • Contact:
          • Site Contact
      • Kuala Lumpur, Malaisie, 50603
        • Recrutement
        • Universiti Malaya Medical Centre (UMMC)
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Soo Kun Lim
    • Kuala Lumpur
      • Kuala Lumpur, Kuala Lumpur, Malaisie, 56000
        • Recrutement
        • Universiti Kebangsaan Malaysia (UKM) - Medical Centre (Pusat Perubatan) (Hospital Canselor Tuanku Muhriz (HCTM))
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Lydia Kamaruzaman
    • Pahang
      • Kuantan, Pahang, Malaisie, 25100
        • Recrutement
        • Hospital Tengku Ampuan Afzan
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Fariz Safhan Mohamad Nor
    • Perak
      • Taiping, Perak, Malaisie, 34000
        • Recrutement
        • Hospital Taiping
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Kok Seng Teng
    • Selangor
      • Kajang, Selangor, Malaisie, 43000
        • Recrutement
        • Hospital Sultan Idris Shah Serdang (Hospital Serdang)
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Li Lian Tay
      • Subang Jaya, Selangor, Malaisie, 47500
        • Recrutement
        • Sunway Medical Centre (SMC)
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Rosnawati Yahya
      • Bergen, Norvège, 5021
        • Recrutement
        • Haukeland Universitetssjukehus
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Thomas Knoop
      • Grålum, Norvège, 1714
        • Recrutement
        • Sykehuset Ostfold
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Dumitrescu Ioana-Elena
      • Stavanger, Norvège
        • Recrutement
        • Stavanger Universitetssjukehus - Helse Stavanger HF
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Goransson Lasse
      • Trondheim, Norvège, 7030
        • Recrutement
        • Universitetssykehuset I Trondheim - St. Olavs Hospital - Nevroklinikken
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Yngvar Haaskjold
    • Akershus
      • Lorenskog, Akershus, Norvège, 1478
        • Recrutement
        • Akershus University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Bartlomiej Witczak
    • Vestfold
      • Tønsberg, Vestfold, Norvège
        • Recrutement
        • Sykehuset I Vestfold
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Kjellevold Stig Arne
      • Leiden, Pays-Bas, 2333 ZA
        • Recrutement
        • Leids Universitair Medisch Center
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Joris Rotmans
      • Nieuwegein, Pays-Bas, 3435CM
        • Recrutement
        • Sint Antonius ziekenhuis Utrecht/Nieuwegein
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Gurbey Ocak
      • Nijmegen, Pays-Bas, 6525 GA
        • Recrutement
        • Radboud Universitair Medisch Centrum
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Raphael Duivenvoorden
      • Utrecht, Pays-Bas, 3584 CX
        • Recrutement
        • UMC Utrecht
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Sabine Meijvis
    • North Holland
      • Amsterdam, North Holland, Pays-Bas, 1105 AZ
        • Recrutement
        • Amsterdam UMC - Locatie AMC (Academisch Medisch Centrum)
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Marc Hilhorst
      • Gmina Świecie, Pologne, 86-100
        • Recrutement
        • Nowy Szpital Sp Zo.o
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Andrzej Brymora
      • Krakow, Pologne, 31-559
        • Recrutement
        • SCM Sp. z o.o.
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Dariusz Aksamit
      • Lodz, Pologne
        • Recrutement
        • Indywidualna Specjalistyczna Praktyka Lekarska
        • Chercheur principal:
          • Michal Nowicki
        • Contact:
          • Site Contact
      • Wroclaw, Pologne, 50-981
        • Recrutement
        • 4th Military Clinical hospital /Polyclinic SP ZOZ
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Magdalena Krajewska
      • Canterbury, Royaume-Uni, CT1 3PA
        • Recrutement
        • Kent & Canterbury Hospital, Canterbury
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Tharindra Somasinghe
      • Hull, Royaume-Uni
        • Recrutement
        • Hull University Teaching Hospitals NHS Trust
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Sunil Bhandari
      • Leicester, Royaume-Uni
        • Recrutement
        • Leicester General Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Chee Kay Cheung
      • London, Royaume-Uni, WC2R 2LS
        • Recrutement
        • King's College Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Sapna Shah
      • London, Royaume-Uni, SW17 0QT
        • Recrutement
        • St George's University Hospitals NHS Foundation Trust
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Richard Hull
      • Nottingham, Royaume-Uni
        • Recrutement
        • Nottingham University Hospitals NHS Trust - City Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Matthew Hall
      • Preston, Royaume-Uni, PR29HT
        • Recrutement
        • Lancashire Teaching Hospital NHS Foundation Trust
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Arvind Ponnusamy
      • Sheffield, Royaume-Uni
        • Recrutement
        • Northern General Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Arif Khwaja
    • Greater London
      • London, Greater London, Royaume-Uni, SE1 9RT
        • Recrutement
        • Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Dimitrios-Anestis Moutzouris
    • United Kingdom of Great Britain and Northern Ireland
      • Birmingham, United Kingdom of Great Britain and Northern Ireland, Royaume-Uni
        • Recrutement
        • Birmingham Heartlands Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Bamidele Tokunbo Ajayi
      • Singapore, Singapour
        • Recrutement
        • National University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Boon Wee Teo
      • Singapore, Singapour, 169608
        • Recrutement
        • Singapore General Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Jason Choo
      • Singapore, Singapour, 308433
        • Recrutement
        • Tan Tock Seng Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • See Cheng Yeo
      • Ljubljana, Slovénie, 1000
        • Recrutement
        • University Medical Centre Ljubljana
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Andreja Ales Rigler
      • Maribor, Slovénie
        • Recrutement
        • University Clinical Centre Maribor
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Sebastjan Bevc
      • Zurich, Suisse, 8091
        • Recrutement
        • University Hospital Zurich
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Britta George
      • Linköping, Suède
        • Recrutement
        • Renal Medicine Linkoping University/ Linkoping University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Annette Bruchfeld
      • Kaohsiung City, Taïwan, 807
        • Recrutement
        • Kaohsiung Medical University - Chung-Ho Memorial Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Yi Wen Chiu
      • New Taipei City, Taïwan
        • Recrutement
        • Taipei Medical University Shuang Ho Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Mai-Szu Wu
      • Taichung, Taïwan, 40705
        • Recrutement
        • Taichung Veterans General Hospital
        • Chercheur principal:
          • Ming-Ju Wu
        • Contact:
          • Site Contact
      • Taichung, Taïwan
        • Recrutement
        • China Medical University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Ping-Chin Lai
      • Zhongzheng, Taïwan, 100
        • Recrutement
        • National Taiwan University Hospital
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Jenq-Wen Huang
      • Olomouc, Tchéquie, 779 00
        • Recrutement
        • Fakultni nemocnice Olomouc
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Karel Krejci
      • Prague, Tchéquie
        • Recrutement
        • First Faculty of Medicine Charles University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Vladimir Tesar
    • Moravskoslezsk Kraj
      • Nový Jičín, Moravskoslezsk Kraj, Tchéquie, 741 01
        • Recrutement
        • Nemocnice AGEL Novy Jicin a.s
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Vaclava Honova
      • Kocaeli, Turquie (Türkiye)
        • Recrutement
        • Kocaeli Universitesi Tip Fakultesi Arastirma ve Uygulama Hastanesi
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Necmi Eren
    • Battalgazi
      • Malatya, Battalgazi, Turquie (Türkiye), 44280
        • Recrutement
        • Turgut Ozal Medical Center
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Ozkan Ulutas
    • Gaziantep
      • Şahinbey, Gaziantep, Turquie (Türkiye), 27310
        • Recrutement
        • Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Fatih Mehmet Erdur
    • Istanbul
      • Fatih, Istanbul, Turquie (Türkiye), 34098
        • Recrutement
        • Istanbul Universitesi Cerrahpasa Tip Fakultesi
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Nurhan Seyahi
    • Melikgazi
      • Kayseri, Melikgazi, Turquie (Türkiye), 38039
        • Recrutement
        • Erciyes University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Bulent Tokgoz
    • Onikisubat
      • Kahramanmaraş, Onikisubat, Turquie (Türkiye), 46040
        • Recrutement
        • Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Avsar Mah
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Orcum Altunoren
    • Selcuklu
      • Konya, Selcuklu, Turquie (Türkiye), 42280
        • Recrutement
        • Necmettin Erbakan University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Kultigin Turkmen
    • Alabama
      • Birmingham, Alabama, États-Unis, 35233-2110
        • Recrutement
        • UAB Nephrology Research Clinic at Paula Building
        • Chercheur principal:
          • Dana Rizk
        • Contact:
          • Site Contact
      • Montgomery, Alabama, États-Unis, 36117
        • Recrutement
        • DCR Montgomery
        • Chercheur principal:
          • Vinayak Ramanath
        • Contact:
          • Site Contact
    • Arizona
      • Surprise, Arizona, États-Unis, 85374
        • Recrutement
        • Panoramic Health - Southwest Kidney Institute, PLC
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Minesh Rajpal
    • California
      • Fremont, California, États-Unis, 94538
        • Recrutement
        • Panoramic Health - West Coast Kidney Institute (Fremont)
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Varun Chawla
      • Los Angeles, California, États-Unis, 90022
        • Recrutement
        • Academic Medical Research Institute
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Mohammed El-Shahwy
      • Los Angeles, California, États-Unis, 90095
        • Recrutement
        • UCLA University of California Los Angeles
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Anjay Rastogi
      • Orange, California, États-Unis, 92868-3201
        • Recrutement
        • University of California Irvine
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Ramy Hanna
      • San Francisco, California, États-Unis, 94118
        • Recrutement
        • Kaiser Permanente San Francisco Medical Center
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Ali Poyan-Mehr
    • Florida
      • Jacksonville, Florida, États-Unis, 32250
        • Recrutement
        • Panoramic Health - Florida Kidney Physicians, LLC (Jacksonville)
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Prasanth Krish
      • Lauderdale Lakes, Florida, États-Unis, 33313-1607
        • Recrutement
        • South Florida Research Institute
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Edouard Martin
      • Melbourne, Florida, États-Unis, 32901
        • Recrutement
        • Panoramic Health - Florida Kidney Physicians, LLC (Melbourne)
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Claus Peter Spies
      • Miami, Florida, États-Unis, 33127
        • Recrutement
        • Bioresearch Partners
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Jose Miguel Cardona-Guzman
      • Miami, Florida, États-Unis, 33176
        • Recrutement
        • Total Health and Research Center (THRC)
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Jeffrey Maldonado
      • Orlando, Florida, États-Unis, 32806
        • Recrutement
        • CTR Oakwater, LLC
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Arvind Madan
      • Pembroke Pines, Florida, États-Unis, 33029
        • Recrutement
        • Bioresearch Partners
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Max Benjamin
      • Riverview, Florida, États-Unis, 33578
        • Recrutement
        • Panoramic Health - Florida Kidney Physicians, LLC (Tampa)
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Amit Augustine Johnsingh
      • Sanford, Florida, États-Unis, 32771
        • Recrutement
        • Infigo Clinical Research LLC
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Sayed Husain
    • Georgia
      • Columbus, Georgia, États-Unis, 31904
        • Recrutement
        • DCR Columbus
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Tamorie Smith
      • East Point, Georgia, États-Unis, 30344
        • Recrutement
        • Panoramic Health - Southeast Kidney Associates
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Charmaine Ifeoma Emelife
    • Idaho
      • Boise, Idaho, États-Unis, 83706
        • Recrutement
        • CARE Institute - Boise Kidney
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Arnold Silva
    • Illinois
      • Chicago, Illinois, États-Unis, 60611
        • Recrutement
        • Northwestern University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Yonatan Peleg
      • Rockford, Illinois, États-Unis, 61107
        • Recrutement
        • Panoramic Health - RNA of Rockford, LLC dba Rockford Nephrology Associates
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Syed Mustafa Ahmed
    • Louisiana
      • Shreveport, Louisiana, États-Unis, 71101
        • Recrutement
        • Northwest Louisiana Nephrology
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Marwan Kaskas
    • Michigan
      • Lansing, Michigan, États-Unis, 48911
        • Recrutement
        • Ingham Nephrology & Hypertension, P.C.
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Brian Cousino
      • Pontiac, Michigan, États-Unis, 48341
        • Recrutement
        • Elixia MKC
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Fahd Al-Saghir
      • Saint Joseph, Michigan, États-Unis, 49085
        • Recrutement
        • Panoramic Health - Lake Michigan Nephrology, PLC
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Oliver Chambers Songlingco
    • Minnesota
      • Edina, Minnesota, États-Unis, 55435
        • Recrutement
        • DCR Edina
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Shannon Doyle
    • Missouri
      • City of Saint Peters, Missouri, États-Unis, 63376
        • Recrutement
        • Elixia MNA
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Gary Singer
      • Kansas City, Missouri, États-Unis, 64111
        • Recrutement
        • Clinical Research Consultants a JCCT Company
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Ahmed Awad
    • New Mexico
      • Albuquerque, New Mexico, États-Unis, 87109
        • Recrutement
        • Renal Medicine Associates - Frenova F1
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Jayant Kumar
    • North Carolina
      • Winston-Salem, North Carolina, États-Unis, 27103
        • Recrutement
        • Brookview Hills Research Associates, LLC
        • Chercheur principal:
          • Nicholas McLean
        • Contact:
          • Site Contact
    • Ohio
      • Cincinnati, Ohio, États-Unis, 45212
        • Recrutement
        • Panoramic Health - Kidney and Hypertension Center
        • Contact:
          • Site Contact
        • Chercheur principal:
          • James Davis
    • Pennsylvania
      • Media, Pennsylvania, États-Unis, 19063
        • Recrutement
        • Panoramic Health - Clinical Renal Associates, Ltd.
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Nathan Okechukwu
      • Philadelphia, Pennsylvania, États-Unis, 19107
        • Recrutement
        • Thomas Jefferson University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Charlene Deng
    • Rhode Island
      • East Providence, Rhode Island, États-Unis, 02914
        • Recrutement
        • Panoramic Health - Nephrology Associates, Inc.
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Larissa Kruger Gomes
    • Texas
      • Dallas, Texas, États-Unis, 75230
        • Recrutement
        • Dallas Renal Group
        • Chercheur principal:
          • Irfan Agha
        • Contact:
          • Site Contact
      • El Paso, Texas, États-Unis, 79902
        • Recrutement
        • DCR - El Paso
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Simon Rodriguez
      • Houston, Texas, États-Unis, 77054
        • Recrutement
        • Provecta Research Network
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Sreedhar Mandayam
      • Houston, Texas, États-Unis, 77030
        • Recrutement
        • Houston Methodist Research Institute - Department of Medicine
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Peter Nguyen
      • Katy, Texas, États-Unis, 77450
        • Recrutement
        • Nephrology Associates of Houston PLLC
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Syed Hussain
      • San Antonio, Texas, États-Unis, 78215
        • Recrutement
        • Sun Research Institute
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Reyes Leonel
      • San Antonio, Texas, États-Unis, 78251
        • Recrutement
        • DCR San Antonio
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Tahira Alves
    • Utah
      • Salt Lake City, Utah, États-Unis, 84115
        • Recrutement
        • Utah Kidney Research Institute
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Sanjiv Anand
    • Virginia
      • Arlington, Virginia, États-Unis, 22205
        • Recrutement
        • Panoramic Health - Virginia Nephrology Group
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Renuka Sothinathan
    • West Virginia
      • Morgantown, West Virginia, États-Unis, 26506
        • Recrutement
        • West Virginia University
        • Contact:
          • Site Contact
        • Chercheur principal:
          • Bethany Pellegrino

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

  • Inclusion Criteria:

To be eligible to participate in this trial, participants must meet all the following criteria:

  1. Either UPCR greater than or equal to (≥) 0.8 gram per gram (g/g) or urine protein excretion (UPE) ≥1 grams per day (g/day), calculated from at least one 24-hour urine collection during the screening period (or pre-screening, if applicable) (only applicable for the main trial).

  2. eGFR greater than (>)30 milliliters per minute per 1.73 meter square (mL/min/1.73m^2) at screening based on the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula (only applicable for the main trial).

  3. No prior exposure to anti- cluster of differentiation 38 (CD38) therapy period (except for open-label cohort participants meeting Inclusion Criterion No. 10.a).

  4. The participant is aged ≥ 18 years or the local legal age as applicable.

  5. The participant (and the participant's legally acceptable representative, as applicable per local regulations or determination) has provided informed consent (that is, in writing, documented via a signed and dated informed consent form [ICF]) and any required privacy authorization before the initiation of any clinical trial procedures.

  6. Diagnosis of primary immunoglobulin A nephropathy (IgAN) supported by a renal biopsy report that is dated more recently than 10 years before the signing of the informed consent for the clinical trial. The redacted report must be made available for review. A renal biopsy must be performed during screening for participants without a biopsy report within 10 years.

  7. Participants must be on stable renin-angiotensin-aldosterone system (RAAS) inhibitor therapy with an angiotensin-converting enzyme inhibitor (ACE-I) and/or angiotensin receptor blocker (ARB) or endothelin receptor antagonist (ERA) or mineralocorticoid receptor antagonist (MRA) agent for at least 12 weeks before signing the ICF with dosing at the maximally tolerated or labeled dose as determined by the investigator, with the intent to continue stable dosing during the clinical trial. Those intolerant of RAAS inhibitor therapy are potentially eligible after consultation with the medical monitor. Intolerance is defined as a documented side effect causing discontinuation of the therapy.

  8. Resting blood pressure less than or equal to (≤)150 millimeters of mercury (mmHg) systolic and ≤100 mmHg diastolic.

  9. Female participants of childbearing potential who are not pregnant during screening (confirmed by negative serum human chorionic gonadotropin [hCG]) and on Visit 1 before first dose of trial intervention (confirmed by negative urine pregnancy test).

  10. Any one of the following (only applicable for participants in the open-label cohort):

    1. Participants in Trial TAK-079-1006 who completed the Week 96 visit or the retreatment period with either UPCR >0.5 g/g or UPE >0.5 g/d calculated from a 24-hour urine collection during the screening period (or pre-screening, if applicable) and eGFR >30 mL/min/1.73m^2 at screening based on the CKD-EPI formula.

    2. UPCR <0.8 g/g and UPE ≥0.75 and <1.0 g/day, by 24-hour urine collection during the screening period (or pre-screening, if applicable) and eGFR > 30 mL/min/1.73m^2 at screening based on the CKD-EPI formula.

    3. UPCR ≥ 0.8 g/g or UPE ≥ 1.0 g/d by 24-hour urine collection during the screening period (or pre-screening, if applicable) and eGFR ≥25 and ≤30 mL/min/1.73m^2 at screening based on the CKD-EPI formula.

      • Exclusion Criteria:

A participant who meets any of the following criteria will be excluded from participation in this trial:

  1. Kidney biopsy exhibiting significant concomitant renal disease other than IgAN (for example, diabetic nephropathy, lupus nephritis, minimal change disease).

  2. Secondary IgAN (such as with significant liver disease, inflammatory bowel disease, and seronegative spondyloarthropathies), and immunoglobulin A (IgA) vasculitis.

  3. Evidence of rapidly progressive glomerulonephritis (loss of ≥50% of eGFR within 3 months before the signing of the ICF).

  4. Diagnosis of nephrotic syndrome defined as 24-hour proteinuria >3.5 g/day and hypoalbuminemia (<3.0 grams per deciliter [g/dL]) with or without peripheral edema.

  5. Renal or other organ transplantation prior to or expected during the clinical trial.

  6. Treatment with oral immunosuppressive agents (including cyclophosphamide, mycophenolate mofetil, cyclosporine, azathioprine, calcineurin inhibitors) or biologic therapy for immunomodulation (including immunomodulatory monoclonal or polyclonal antibodies) within 6 months (both B-cell and non-B-cell directed agents) before signing of the ICF.

  7. If the participant has received anti-CD20 treatment, the participant is excluded if either of the following apply:

    1. The last dose was received within 6 months before the signing of the ICF.
    2. The last dose was received between 6 and 12 months before the signing of the ICF and the participant has a CD19+ count below the lower limit of normal.

    Note: Participants who have received the last dose of anti-CD20 treatment >12 months before the signing of the ICF are not excluded from clinical trial participation based on this criterion and are not required to undergo CD19+ testing.

  8. Within 4 months of the screening visit, use of either a) systemic corticosteroids at an average dose of 40 milligrams (mg) prednisone equivalent or higher for more than 14 days or b) oral budesonide delayed release capsules.

  9. The participant has received a live or live-attenuated vaccine within 4 weeks before signing the ICF or has any live or live-attenuated vaccine planned during the clinical trial.

  10. Participation in any other investigational drug trial (including vaccine trial) with receipt of at least 1 dose of investigational drug, or has been exposed to another investigational agent within 4 weeks or 5 half-lives, whichever is longer, before Visit 1.

  11. The participant has active infection with hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV).

  12. The participant has had any of the following types of infections within the specified timeframes where applicable:

    1. Active bacterial, viral, or fungal infection (except for the common cold and onychomycosis), or any other serious infection within 2 weeks of signing the ICF. Any anti-infective course for infection must be completed at least 2 weeks before Visit 1.
    2. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) infection within 4 weeks of signing the ICF.
    3. Opportunistic infection or treatment for an opportunistic infection less than or equal to (≤)12 weeks before signing the ICF.
    4. Active tuberculosis (TB), any history of prior active TB, or any signs or symptoms of active TB infection (including but not limited to chronic fever, chronic productive cough, night sweats, weight loss, or malnutrition) as judged by the investigator.
    5. For participants in European Union (EU) member states, positive or 2 indeterminant QuantiFERON results, unless there is documentation of prior complete treatment for latent TB, or participant has initiated prophylaxis based on local guidelines and in consultation with a pulmonology or infectious disease specialist prior to the first administration of IMP.
  13. In the opinion of the investigator, the participant is currently experiencing any medical condition that might interfere with participation in the trial (for example, significant ocular, cardiovascular, pulmonary, hematologic, gastrointestinal, endocrinologic, hepatic, renal, neurologic, malignancy, infectious disease, immunodeficiency, or alcohol and drug abuse), that poses an added risk for the participant or could confound the assessment of trial results.

  14. In the opinion of the investigator, the participant has a serious medical or psychiatric illness that could potentially interfere with the completion of treatment.

  15. The participant has a history of major surgery within 3 months before screening (or longer, at the discretion of the investigator); or, either has a planned tonsillectomy or underwent a tonsillectomy within 6 months before screening.

    Note: Major surgery typically requires at least 1 night in the hospital.

  16. History of malignancy (including myelodysplastic syndrome) within 5 years of signing the ICF, except for adequately treated non-melanoma skin cancer, superficial bladder cancer, and curatively treated cervical carcinoma-in-situ.

  17. The participant has a history of a severe allergic or anaphylactic reaction to recombinant proteins or excipients used in the mezagitamab or placebo formulation.

  18. The participant has (1) been diagnosed with or has suspected chronic obstructive pulmonary disease (COPD) or asthma and (2) has a prebronchodilatory forced expiratory volume in 1 second (FEV1) <50% of predicted normal at screening.

  19. The participant is capable of breastfeeding but does not agree to forego breastfeeding from first dose of investigational medicinal product (IMP) through 30 days after the last dose of IMP.

  20. The participant is an individual with potential for pregnancy but does not agree to use at least 1 form of highly effective contraception and 1 barrier method of contraception (preferably male condom) when engaging in heterosexual sex for the protocol specified duration after the last dose of IMP.

  21. The participant is a sexually active, non-sterilized individual who produces sperm but does not agree to use a barrier method (preferably male condom) combined with at least 1 form of highly effective contraception for any partner(s) with potential for pregnancy when engaging in heterosexual sex for the protocol specified duration after the last dose of IMP.

  22. In the investigator's opinion, the participant (and the participant's legally acceptable representative, if applicable per local regulations or determination) is unwilling and/or unable to understand and fully comply with clinical trial procedures and requirements (including digital tools and applications).

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Quadruple

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Mezagitamab

Participants will receive mezagitamab injections, subcutaneously (SC), for approximately 22 weeks.

Mezagitamab injections administered SC.

Autres noms:
  • TAK-079
Comparateur placebo: Placebo

Participants will receive mezagitamab-matching placebo injections, SC for approximately 22 weeks.

Mezagitamab-matching placebo injections administered SC.

Expérimental: Open-label Mezagitamab

Participants will receive mezagitamab injections, SC for approximately 22 weeks.

Mezagitamab injections administered SC.

Autres noms:
  • TAK-079

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change from Baseline in Proteinuria at Week 36
Délai: From Baseline to Week 36

Proteinuria will be assessed by urine protein to creatinine ratio (UPCR) calculated from a 24-hour urine collection.

From Baseline to Week 36

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Changement par rapport à la référence dans le taux de filtration glomérulaire estimé (EGFR) aux semaines 52 et 104, respectivement
Délai: De la ligne de base aux semaines 52 et 104
De la ligne de base aux semaines 52 et 104
Time From Baseline to the First Occurrence of Sustained Decline in eGFR of ≥30 Percent (%) From Baseline Over at Least 4 Weeks
Délai: From Baseline to Week 104
From Baseline to Week 104
Percentage of Participants Who Achieve ≥30% Reduction From Baseline in Proteinuria at Week 104
Délai: From Baseline to Week 104
From Baseline to Week 104
The Rate of Change in eGFR From Baseline at Week 104
Délai: From Baseline to Week 104

The rate of change in eGFR from baseline is measured as eGFR total slope.

From Baseline to Week 104
Time from Baseline to the First Occurrence of Any of the Pre-specified Kidney Failure Composite Assessment Criteria
Délai: From Baseline to Week 104

The pre-specified assessment criteria will include: sustained decline in eGFR of ≥30% from baseline over at least 4 weeks; sustained eGFR <15 mL/min/1.73 m^2 over at least 4 weeks; initiation of maintenance dialysis defined as dialysis performed for at least 4 weeks; receipt of kidney transplant; or death from kidney failure. Time from baseline to first occurrence of any of the above assessment criteria would be reported.

From Baseline to Week 104

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Les enquêteurs

  • Directeur d'études: Study Director, Takeda

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

15 juillet 2025

Achèvement primaire (Estimé)

7 septembre 2028

Achèvement de l'étude (Estimé)

14 janvier 2030

Dates d'inscription aux études

Première soumission

30 avril 2025

Première soumission répondant aux critères de contrôle qualité

30 avril 2025

Première publication (Réel)

9 mai 2025

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

4 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

3 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • TAK-079-3001
  • 2025-520825-19-00 (Ctis)
  • 2025 (Subvention/contrat des NIH des États-Unis)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

Takeda provides access to the de-identified individual participant data (IPD) for eligible studies to aid qualified researchers in addressing legitimate scientific objectives (Takeda's data sharing commitment is available on https://clinicaltrials.takeda.com/takedas-commitment?commitment=5). These IPDs will be provided in a secure research environment following approval of a data sharing request, and under the terms of a data sharing agreement.

Critères d'accès au partage IPD

IPD from eligible studies will be shared with qualified researchers according to the criteria and process described on https://vivli.org/ourmember/takeda/. For approved requests, the researchers will be provided access to anonymized data (to respect patient privacy in line with applicable laws and regulations) and with information necessary to address the research objectives under the terms of a data sharing agreement.

Type d'informations de prise en charge du partage d'IPD

  • PROTOCOLE D'ÉTUDE
  • SÈVE
  • CIF
  • RSE

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Oui

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner